IN Brief:
- Six construction and fertiliser partners have made commitments representing more than €50 million in annual turnover.
- GypCarb converts industrial carbon dioxide into engineered calcium carbonate for cement and concrete applications.
- A UK demonstration plant is targeted for 2027 before a larger European production facility planned for 2029.
Vateris has secured binding offtake agreements and letters of intent with six international partners for materials produced through its carbon mineralisation process, with the combined commitments representing more than €50 million in annual turnover. Holcim, Marshalls, and Goldbeck have committed to GypCarb, an engineered calcium carbonate intended for cement and concrete applications, while Waypoint and two unnamed international fertiliser businesses have committed to sulphate of potash. The package combines binding volumes from a proposed UK demonstration plant with larger non-binding commitments associated with a planned European main plant.
Vateris expects the UK demonstration facility to begin production in 2027, with its first full industrial-scale European plant targeted for 2029. Letters of intent cover volumes equivalent to 130% of the proposed main plant’s planned output, according to the company, giving the development a customer pipeline before final investment decisions are completed.
The construction commitments involve three established businesses operating across cement, concrete products, building systems, and construction materials. Their involvement gives Vateris identified industrial customers for material produced during the next stage of scale-up, moving GypCarb beyond laboratory work and isolated trials towards commercial qualification and supply.
GypCarb is produced by converting industrial flue-gas carbon dioxide into an engineered calcium carbonate. Vateris describes the material as a drop-in mineral additive that can be introduced into existing cement and concrete production processes, with the aim of reducing cement content while maintaining or improving material performance. Carbon dioxide is mineralised into the product rather than retained as a separate captured stream.
That approach enters a concrete market already dealing with tighter availability of some conventional supplementary cementitious materials and a growing range of alternative low-carbon technologies. Producers are assessing alternative binders, carbon mineralisation, carbon curing, and carbon capture while still having to meet structural, durability, production, and cost requirements. Technologies that can operate within existing batching and manufacturing systems avoid one source of capital expenditure, although they still require qualification at material and project level.
Vateris has already run GypCarb trials with Marshalls at two UK production facilities. Wet-cast concrete trials at West Lane and block-paving work at St Ives recorded early-age strength improvements and reductions in carbon intensity, according to Vateris, without requiring wholesale changes to the existing production process. Those results remain company-reported, but they provide a technical basis for the commercial commitment now being taken forward.
The company has also secured strategic investment from businesses linked to construction materials. Holcim invested in Vateris earlier in 2026 alongside Kiilto Ventures and existing investors, taking total funding reported by Vateris to $10 million. The funding has been directed towards the transition from pilot validation to larger-scale industrial deployment.
The proposed demonstration plant is the next engineering test. Continuous production has to prove process stability, product consistency, maintenance requirements, energy use, and logistics at volumes beyond a pilot line, while supplying enough material for customers to complete their own qualification programmes. Binding offtake gives that plant identifiable demand, but operating performance will determine whether the process can support the larger European investment envisaged for 2029.
Construction-material decarbonisation is already moving into live project specifications. A recent central London project has adopted concrete containing carbon-captured cement, demonstrating how technologies that were previously confined to pilots are beginning to enter procurement decisions on commercial developments.
Vateris’ route differs because the captured carbon is converted into a mineral additive intended to reduce the quantity of conventional cement required in a mix. Concrete producers will therefore judge the material on familiar measures: strength development, durability, consistency, cost, standards compliance, availability, and the effect on plant throughput. A carbon figure that cannot survive those requirements has little commercial value on a production line.
The sulphate-of-potash output also influences the economics of the proposed process. Selling products into construction and fertiliser markets provides two potential revenue streams from the same carbon-to-materials platform, although each product carries different specifications, customers, logistics, and qualification requirements. The six current partners therefore provide demand signals across both sides of the proposed operation.
Vateris now has to convert commercial interest into repeatable industrial output. The UK demonstration plant will establish whether the process can maintain quality and economics under continuous operation; if it does, the 2029 European facility would turn GypCarb from an emerging materials technology into a larger-scale supply proposition for cement and concrete producers.
